The concurrent mutations of C26 N/N53F can reduce the antigenic propensity of nsLTP2 as an anti-tumor or viral drug carrier

by Samira Rahimirad, Najaf Allahyari Fard, Raheleh Mirzabeygi, Behnam Mortazavi
Published 2021-01-01